☰

David W. Woessner, Ph.D.

Affiliations: 
Pharmacology and Toxicology University of Utah, Salt Lake City, UT 
Area:
Basal Ganglia Structure and Function
Google:
"David Woessner"
Mean distance: 16.06 (cluster 6)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Kristen A. Keefe grad student 2013 University of Utah
 (New strategies for targeted chronic myeloid leukemia therapy: Disrupting BCR-ABL1 dimerization and secondary leukemia-specific pathways.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chang Y, Woessner DW, Lin W, et al. (2018) Abstract IA12: Modeling and targeting CREBBP mutations in relapsed acute lymphoblastic leukemia Cancer Research. 78
Woessner DW, Eiring AM, Bruno BJ, et al. (2015) A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia. Leukemia
Miller GD, Woessner DW, Sirch MJ, et al. (2013) Multidomain targeting of Bcr-Abl by disruption of oligomerization and tyrosine kinase inhibition: toward eradication of CML. Molecular Pharmaceutics. 10: 3475-83
Woessner DW, Lim CS. (2013) Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation. Molecular Pharmaceutics. 10: 270-7
Miller GD, Woessner DW, Lim CS. (2013) Abstract 2170: Development of a "dual-hit" combination therapy for CML. Cancer Research. 73: 2170-2170
Constance JE, Woessner DW, Matissek KJ, et al. (2012) Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib. Molecular Pharmaceutics. 9: 3318-29
Dixon AS, Miller GD, Bruno BJ, et al. (2012) Correction to "improved coiled-coil design enhances interaction with bcr-abl and induces apoptosis". Molecular Pharmaceutics. 9: 1535
Dixon AS, Miller GD, Bruno BJ, et al. (2012) Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis. Molecular Pharmaceutics. 9: 187-95
Woessner DW, Lim CS. (2012) Abstract 5615: Combination therapy for chronic myelogenous leukemia: Targeting the BCR-ABL coiled-coil domain and other pathways for synthetic lethality Cancer Research. 72: 5615-5615
Woessner DW, Lim CS, Deininger MW. (2011) Development of an effective therapy for chronic myelogenous leukemia. Cancer Journal (Sudbury, Mass.). 17: 477-86
See more...